Fiber Intake and Survival After Colorectal Cancer Diagnosis
- PMID: 29098294
- PMCID: PMC5776713
- DOI: 10.1001/jamaoncol.2017.3684
Fiber Intake and Survival After Colorectal Cancer Diagnosis
Erratum in
-
Incomplete Conflict of Interest Disclosures.JAMA Oncol. 2019 Apr 1;5(4):579. doi: 10.1001/jamaoncol.2019.0286. JAMA Oncol. 2019. PMID: 30844032 Free PMC article. No abstract available.
Abstract
Importance: Although high dietary fiber intake has been associated with a lower risk of colorectal cancer (CRC), it remains unknown whether fiber benefits CRC survivors.
Objective: To assess the association of postdiagnostic fiber intake with mortality.
Design, setting, and participants: A total of 1575 health care professionals with stage I to III CRC were evaluated in 2 prospective cohorts, Nurses' Health Study and Health Professionals Follow-up Study. Colorectal cancer-specific and overall mortality were determined after adjusting for other potential predictors for cancer survival. The study was conducted from December 23, 2016, to August 23, 2017.
Exposures: Consumption of total fiber and different sources of fiber and whole grains assessed by a validated food frequency questionnaire between 6 months and 4 years after CRC diagnosis.
Main outcomes and measures: Hazard ratios (HRs) and 95% CIs of CRC-specific and overall mortality after adjusting for other potential predictors for cancer survival.
Results: Of the 1575 participants, 963 (61.1%) were women; mean (SD) age was 68.6 (8.9) years. During a median of 8 years of follow-up, 773 deaths were documented, including 174 from CRC. High intake of total fiber after diagnosis was associated with lower mortality. The multivariable HR per each 5-g increment in intake per day was 0.78 (95% CI, 0.65-0.93; P = .006) for CRC-specific mortality and 0.86 (95% CI, 0.79-0.93; P < .001) for all-cause mortality. Patients who increased their fiber intake after diagnosis from levels before diagnosis had a lower mortality, and each 5-g/d increase in intake was associated with 18% lower CRC-specific mortality (95% CI, 7%-28%; P = .002) and 14% lower all-cause mortality (95% CI, 8%-19%; P < .001). According to the source of fiber, cereal fiber was associated with lower CRC-specific mortality (HR per 5-g/d increment, 0.67; 95% CI, 0.50-0.90; P = .007) and all-cause mortality (HR, 0.78; 95% CI, 0.68-0.90; P < .001); vegetable fiber was associated with lower all-cause mortality (HR, 0.83; 95% CI, 0.72-0.96; P = .009) but not CRC-specific mortality (HR, 0.82; 95% CI, 0.60-1.13; P = .22); no association was found for fruit fiber. Whole grain intake was associated with lower CRC-specific mortality (HR per 20-g/d increment, 0.72; 95% CI, 0.59-0.88; P = .002), and this beneficial association was attenuated after adjusting for fiber intake (HR, 0.77; 95% CI, 0.62-0.96; P = .02).
Conclusions and relevance: Higher fiber intake after the diagnosis of nonmetastatic CRC is associated with lower CRC-specific and overall mortality. Increasing fiber consumption after diagnosis may confer additional benefits to patients with CRC.
Conflict of interest statement
No other conflict of interest exists.
Figures
Comment in
-
Fiber Intake and Colorectal Cancer-Reply.JAMA Oncol. 2018 Aug 1;4(8):1135. doi: 10.1001/jamaoncol.2018.0901. JAMA Oncol. 2018. PMID: 29879263 No abstract available.
-
Fiber Intake and Colorectal Cancer.JAMA Oncol. 2018 Aug 1;4(8):1135. doi: 10.1001/jamaoncol.2018.0878. JAMA Oncol. 2018. PMID: 29879272 No abstract available.
-
Omitted Disclosures of Potential Conflicts of Interest in Articles Published in JAMA Oncology.JAMA Oncol. 2019 Apr 1;5(4):578-579. doi: 10.1001/jamaoncol.2019.0235. JAMA Oncol. 2019. PMID: 30844040 No abstract available.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: a cancer journal for clinicians. 2016;66(1):7–30. - PubMed
-
- Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA: a cancer journal for clinicians. 2016;66(4):271–289. - PubMed
-
- Jones LW, Demark-Wahnefried W. Diet, exercise, and complementary therapies after primary treatment for cancer. The Lancet Oncology. 2006;7(12):1017–1026. - PubMed
-
- Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA: a cancer journal for clinicians. 2012;62(4):243–274. - PubMed
MeSH terms
Substances
Grants and funding
- R35 CA197735/CA/NCI NIH HHS/United States
- R01 CA118553/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- U01 CA167552/CA/NCI NIH HHS/United States
- K24 DK098311/DK/NIDDK NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- R01 CA169141/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- R01 CA202704/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- R01 CA151993/CA/NCI NIH HHS/United States
- U01 CA176726/CA/NCI NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- R01 CA176272/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
